Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5%
September 01, 2014
Wellesley, Mass., Sep 01, 2014 –BCC Research (www.bccresearch.com) reveals in its new report, Blood-Brain Barrier Technologies and Global Markets, the global market for blood-brain barrier (BBB) technology reached $21.8 million in 2013 and is expected to reach $38.7 million in 2014. This is anticipated to further grow to $471.5 million by 2019, which is equivalent to 64.9% compound annual growth rate (CAGR) from 2014 through 2019. The receptor-mediated transport (RMT) segment is forecasted to grow at a CAGR of 63.8%.
BBB technologies are poised to open up a vast untapped potential in the growing central nervous system therapeutic market, where today growth is limited by the complexity of this layer.
Emerging markets will make up the minority once approvals abroad go through, but numbers will climb over time. Emerging markets include China, Russia, Brazil, India, Turkey, Pakistan, Egypt, Ukraine, Venezuela, South Africa, Mexico, Argentina, Thailand, Vietnam and Indonesia. Growth in Latin America is estimated to rise by about 10.5% CAGR over the same period, while the United States and Europe should see negative growth, as sales of drugs already on the market in these areas remain stagnant. The Japanese market is expected to grow by around 4% CAGR from 2012 to 2017.
“These predictions are more conservative than BCC Research’s last estimates on BBB technologies and reflects a still recovering global economy, as well as investors who desire to preserve capital,” says BCC Research analyst Kim Lawson. “The current market participants are slow to move past various technological hurdles to find new solutions to scientific issues, and appear to have a wait-and-see strategy in developing the best partnerships that could fuel quicker solutions.”
Blood-Brain Barrier Technologies and Global Markets defines the various BBB technologies and provides their history in medicine. The report also looks at the types and technology categories, major companies, impact on the pharmaceutical market, applications, current market values, growth potential and significant trends.

Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC, 49-2 Walnut Park, Wellesley, MA 02481, Telephone: (+1) 781-489-7301; Email: editor@bccresearch.com as the source and publisher. Thank you.
Blood-Brain Barrier Technologies and Global Markets( PHM075B )
Publish Date: Jul 2014
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Pharmaceuticals
- Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030
- Targeted Alpha Therapies Market to Grow at 44% CAGR Globally by 2030
- Global Anti-Parkinson's Drugs Markets Projected to Reach $9.2 Billion by the End of 2030
- Rheumatoid Arthritis Therapies Market to Hit $41.1B by 2030
- Infectious Disease Therapies Market Projected to Reach $101 Billion by End of 2030
Reports from Pharmaceuticals
Recent News
- Global Patient Monitoring Market to Reach $55.8 Billion by End of 2030
- Biomarker Deals Accelerate: Strategic Alliances Reshape Life Sciences Innovation
- China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030
- Global Market for Biological and Medical Imaging Reagents Set to Surge to $40.1 Billion by 2030
- mRNA Market Forecast: Small Decline of -0.04% CAGR by 2030
